Brief: Adagene Reports Full Year 2021 Financial Results
March 31 (Reuters) - Adagene Inc 978y.F :
* ADAGENE REPORTS FULL YEAR 2021 FINANCIAL RESULTS AND
PROVIDES
CORPORATE UPDATE
* ADAGENE INC - CASH AND CASH EQUIVALENTS WERE US$174.4
MILLION AS
OF DECEMBER 31, 2021, COMPARED TO US$75.2 MILLION AS OF DECEMBER
31, 2020
Source text for Eikon: ID:nGNX26J3SM
Further company coverage: 978y.F
((reuters.briefs@thomsonreuters.com;))
Recent news on Adagene
See all newsBrief: Adagene To Begin Phase 1 Study Of ADG138 For Advanced Solid Tumors In Q4 2026
Brief: Adagene Announces That Third Arc Bio Has Selected First Lead Candidate Under Amended Strategic Collaboration For Development Of Masked Cd3 T Cell Engagers Utilizing Safebody® Technology
Brief: Adagene Inc Announces Offering Of American Depositary Shares
Brief: Adagene Announces FDA Fast Track Designation For Muzastotug (Adg126)
Brief: Adagene Expands SAFEBody Deal With Exelixis To Develop Third Novel Masked Antibody-Drug Conjugate